An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma - Wikidata - awgldk - TriplyDB

An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

http://www.wikidata.org/entity/Q27024830

about

Overview of current immunotherapeutic strategies for glioma Clinical efficacy of tumor antigen-pulsed DC treatment for high-grade glioma patients: evidence from a meta-analysis Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme Immunocompetent murine models for the study of glioblastoma immunotherapy Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors.The future of high-grade glioma: Where we are and where are we going.Gene therapy for cancer: present status and future perspective Induction of antigen-specific cytotoxic T-cell response by dendritic cells generated from ecto-mesenchymal stem cells infected with an adenovirus containing the MAGE-D4a gene.Recent advances and future of immunotherapy for glioblastoma.Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme.An Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors.How to train glioma cells to die: molecular challenges in cell death.Cellular immunotherapy for malignant gliomas.The Safety of available immunotherapy for the treatment of glioblastoma.Recent progress in GM-CSF-based cancer immunotherapy.Applied Cancer Immunogenomics: Leveraging Neoantigen Discovery in Glioblastoma.Type 1 Immune Mechanisms Driven by the Response to Infection with Attenuated Rabies Virus Result in Changes in the Immune Bias of the Tumor Microenvironment and Necrosis of Mouse GL261 Brain Tumors.Selection of suitable reference genes for expression analysis in human glioma using RT-qPCR.The Long and Winding Road: From the High-Affinity Choline Uptake Site to Clinical Trials for Malignant Brain Tumors.Prospect of Immunotherapy for Glioblastoma: Tumor Vaccine, Immune Checkpoint Inhibitors and Combination Therapy Cellular immunotherapy directed against human cytomegalovirus as a novel approach for glioblastoma treatment.Cracking the glioma-NK inhibitory code: toward successful innate immunotherapy.Maximizing output from current glioma vaccine trials to construct robust next-generation immunotherapies.Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy.Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients.Re-defining response and treatment effects for neuro-oncology immunotherapy clinical trials.Current state and future prospects of immunotherapy for glioma.Therapeutic cancer vaccines.Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma

P2860

Q26776345-A997B7B5-4617-453C-A794-08C0AB55E813 Q27348437-3C4B8B20-1448-4DB0-92E6-AF7A5607A610 Q28087485-E4D8CDFA-32CD-47B4-BF20-45D5BA55578F Q33574853-2AFA52A1-58BF-494D-8A49-6678DEFBF79D Q34276759-D0C9B053-9221-43EB-951B-9D4148556AE7 Q35114090-F391A59A-0C8E-4354-9761-6CF152F1CF71 Q35673900-55B5981D-49E0-4FA3-8F7F-FE60FB668547 Q35988047-17D0CC19-6175-4295-8276-BD451BABAC16 Q37239071-ADB95C04-DA34-4C44-8F00-F839372FB72A Q37730613-EDD45330-2CE8-410E-8D4A-82552B41C59A Q38262132-B7161645-5BA1-453B-9DE7-F93AE317012E Q38603909-F51CFEB6-6D2B-4D50-B0C9-ED2D65F6237C Q38626416-EDDD84E3-B91A-4F77-85DB-3AC52AC5C83D Q38902169-63D7141E-368A-4B4D-AFB4-95B418779BF4 Q39042442-78E5DF1B-FD0C-44A0-B89A-795F58883256 Q39183386-94ECE6D4-CF3E-4CB0-BC54-32CD51984BD5 Q39243060-C293D55C-EF23-48A2-8B39-692ACCAC1EA8 Q40219738-29E639CA-575F-4C42-BD61-F3F54C0B646A Q41090596-F19423CC-FE09-4C6D-9B16-92941DA9E5B5 Q41189810-35440683-183D-492E-96DA-A3E682CC15A6 Q41485890-7A3915F8-F8A0-47FE-AF61-BA49202CCA3B Q41961885-5FE1905C-83A7-4710-B354-665E47AF6C13 Q43103834-B81FDCE4-959D-4B9C-A621-4966247AEB3D Q44600407-2DC461D2-35FE-4DEF-8A73-8627EC0DE04C Q46512368-6A5F53B6-ED64-4D66-BAC0-7DC0C4D71FBC Q47318878-50CA9ABE-76AD-403C-A23B-FA95B1B2A3E3 Q48314259-C755E6C9-66B8-43A3-96FC-3D531F6E2A0A Q50109459-AC69D96B-830F-42C7-9FB1-01BAFE1F417D Q50988785-BACD6B94-A0E7-4015-8D25-737248F7B176 Q57153312-82A521AB-8EF3-4F57-8E1F-503C8CF7B43C

P2860

An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

http://www.wikidata.org/entity/Q27024830

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

@ast

An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

@en

An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

@nl

type

label

An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

@ast

An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

@en

An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

@nl

prefLabel

An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

@ast

An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

@en

An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

@nl

P1433

Q27024830-77BF507E-ABEF-47D3-8A8D-BC65FBCA9603

P1476

Q27024830-5E3F3DC0-5BDF-4238-B347-8919A38B5D01

P2093

Q27024830-018C4311-EAD3-452E-B7FC-6C4DF592F942

Q27024830-053821C6-1B34-4ADF-9C08-19F274727322

Q27024830-0CA27890-EC39-47AA-9189-824A664C9017

Q27024830-2774EC59-512C-4278-AF3A-64098C02EF36

Q27024830-369F1843-822F-431D-9EA2-E1B28ED7D81E

Q27024830-501DF50B-8239-42AD-AF83-E5AFC9B4CD54

Q27024830-80416E49-2DC5-4740-9E9E-7F79F5D057A5

Q27024830-B2DE3BF5-CE69-490B-AD5F-01A0A0DAE0C3

Q27024830-D626E173-F893-43D6-9D6A-6FE239018423

Q27024830-DE5079FF-1D67-4D7C-9168-BDC2F6DA6FD0

P2860

Q27024830-012F834E-9D69-42BE-B56F-EB15F8D0492C

Q27024830-01852E3F-92C3-44E3-B0FA-8AA9619DE174

Q27024830-026F8571-1C7E-484C-BC4A-09CD717C876A

Q27024830-034B2E54-1DA4-442C-8043-3FADA84F72B6

Q27024830-03BBF164-7739-42E6-ACCC-946681E4A74C

Q27024830-053EE668-6125-4D70-9AEF-7BAD06F58290

Q27024830-055E0E55-5D19-4725-BB3F-C6DAB45A6D87

Q27024830-0561E89E-3D46-4E3D-89D9-751CFFEEAC20

Q27024830-05BD07B5-088D-490C-A9B8-486A496625FE

Q27024830-07AA6FC1-5132-49C5-9847-1DEB2EFC25E7

P304

Q27024830-259CA3A2-0EF9-4CD9-97F6-8B36475EB7D3

P31

Q27024830-DB655A5C-3C90-4425-9256-5787E209AD0D

P356

Q27024830-47D4D1B0-2A91-4038-A38B-278BD45C9BDA

P407

Q27024830-73F0FFDF-7003-4C68-B475-0082A51ACA1C

P433

Q27024830-AC4E0A4D-9EB3-4A50-8F6F-107FCB523DA3

P478

Q27024830-1C6088F7-7E14-4E4D-940C-2FE06459E456

P50

Q27024830-59B0C5E3-A0B0-424B-94CB-F7BC5A0725A3

P577

Q27024830-938AB85A-8D71-4DFE-BE44-D9900EF3DF42

P698

Q27024830-45C3215D-FAF9-4E5B-A25A-DCECC1B4103D

P921

Q27024830-0ED82D68-0B33-4254-8261-A9070E06713D

P932

Q27024830-417E31F4-4D7C-4EF5-A7AA-1E39D02931F0

P356

P1433

Expert Review of Vaccines

P1476

An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma

@en

P2093

Catherine J Wu

http://www.w3.org/2001/XMLSchema#string

Duane A Mitchell

http://www.w3.org/2001/XMLSchema#string

E Antonio Chiocca

http://www.w3.org/2001/XMLSchema#string

Glenn Dranoff

http://www.w3.org/2001/XMLSchema#string

Gordon Freeman

http://www.w3.org/2001/XMLSchema#string

John H Sampson

http://www.w3.org/2001/XMLSchema#string

Kai W Wucherpfennig

http://www.w3.org/2001/XMLSchema#string

Patrick Y Wen

http://www.w3.org/2001/XMLSchema#string

Peter E Fecci

http://www.w3.org/2001/XMLSchema#string

William T Curry

http://www.w3.org/2001/XMLSchema#string

P2860

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype

CNS immune privilege: hiding in plain sight.

An integrated genomic analysis of human glioblastoma multiforme

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

P304

597-615

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERV.13.41

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

David A Reardon

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23750791

http://www.w3.org/2001/XMLSchema#string

P921

P932

3982399

http://www.w3.org/2001/XMLSchema#string